News Notes
Epicur Pharma Partners with Bova to Introduce Injectable Omeprazole for Equine Gastric Disease in the U.S.
Epicur Pharma, a division of Stokes Healthcare and a 503B outsourcing facility of veterinary medications, added omeprazole injection suspension for horses to its product portfolio.
In partnership with the Bova group (https://bova.vet), a leading compounding pharmacy in Australia and a specials manufacturer in the United Kingdom, Epicur is bringing the same unique, proven formulation of omeprazole injection to the United States to treat equine gastric ulcers.
Equine gastric disease, an umbrella term describing 2 different diseases in the horse’s stomach—equine squamous gastric disease (ESGD) and equine glandular gastric disease (EGGD)—is common, and equine veterinarians have been treating the disease for decades with an oral paste administered daily. Epicur’s release of omeprazole as an injection offers veterinarians an innovative alternative for equine gastric ulcers. Benefits of this formulation include:
- Consistent acid suppression compared with oral treatment and, as a result, consistently better treatment responses in published studies
- Improved compliance with medication as only 1 injection is required every 5 to 7 days, rather than oral administration
- No need to withhold feed or other medications prior to administration
- More rapid healing with ESGD healing in 10 days and EGGD in 20 days with the injection, compared to the traditional month of treatment with oral treatment
- Clinical cure in recalcitrant situations
- 100% manufactured following FDA-enforced regulations
“We are excited to introduce another of Bova’s groundbreaking drugs—this time to equine veterinarians across the U.S. We partnered with Bova because we were impressed by their years of dedicated research and the clinical studies that back their unique formulations. The omeprazole injection suspension is truly a game-changer for equine gastric disease,” said Epicur President Michael Tursi.
With the U.S. launch of the omeprazole injection in December 2024, Epicur also welcomed Brett Davidson to the team to lead the company’s equine division. He was the former Bova National Sales Manager in Australia. “Given my experience with the equine products that Epicur and Stokes are launching, I’m eager to help the team expand their footprint in the U.S. equine market,” said Davidson.
Epicur’s omeprazole injection is now available to ship nationwide, with only 1-2 business days in transit. Learn more about the formulation and how to order it at epicurpharma.com/omeprazole-injection. MEV
